-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
With the improvement of people's quality of life and changes in dietary structure, the incidence of hyperuricemia has been increasing year by year, and has become the fourth highest after the three highs
According to the HMAS medical institution market analysis system, the market size of anti-gout drugs in the Shanghai hospital market is increasing year by year.
Market scale of anti-gout drugs in Shanghai hospital market from January 2020 to August 2021 (unit: ten thousand yuan)
At present, anti-gout drugs mainly include five drugs: febuxostat, benzbromarone, Qingpeng ointment, allopurinol and colchicine
Market share of generic names of anti-gout drugs in Shanghai hospital market in 2021
Changes in the market size of anti-gout drugs in the Shanghai hospital market from January 2021 to August 2021 and the same period in 2020
(Unit: ten thousand yuan)
Among the commonly used treatment drugs, febuxostat and allopurinol are xanthine oxidase inhibitors (XOI), which can inhibit the production of uric acid; benzbromarone is a traditional URAT1 inhibitor, which can promote uric acid excretion; colchicine is a preventive agent Drugs for acute attacks of recurrent gouty arthritis
2021 Shanghai hospital market benzbromarone & febuxostat market share of different hospital-level hospitals
However, the main anti-gout drugs currently on the market have certain risks in terms of safety
In the field of anti-gout drugs, major companies have made frequent actions.